NCT02627131

Autologous Bone Marrow Stem Cell Therapy for Autism

Autologous Bone Marrow Stem Cell Therapy for Autism: An Open Label Uncontrolled Clinical Trial

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Vinmec Healthcare System · Academic / Other
• Sex: All
• Age: 3 Years – 16 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study was to evaluate the safety and effectiveness of autologous bone marrow mononuclear stem cells in the management of autism.

Detailed description

The aim of this study was to evaluate the safety and effectiveness of autologous bone marrow mononuclear stem cells in the management of autism of 24 patients at Vinmec International Hospital, Hanoi, Vietnam

Conditions

• Autistic Disorder

Interventions

Type	Name	Description
BIOLOGICAL	Autologous Bone Marrow Mononuclear Cells	Transplantation of Autologous Bone Marrow Mononuclear Cells

Timeline

• Start date: 2014-04-01
• Primary completion: 2015-12-01
• Completion: 2015-12-01
• First posted: 2015-12-10
• Last updated: 2015-12-10

Locations

1 site across 1 country: Vietnam